FSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of Directors - Seite 2

Dr. Hoskins’ list of achievements and accolades is unparalleled. Amongst other things, he was the recipient of the United Nations Association in Canada's Lester B. Pearson Peace Medal, awarded the Meritorious Service Cross by the Governor General of Canada, presented with the Ministry of Citizenship and Immigration Citation for Citizenship, and recognized as a member of Canada's Top 40 Under 40.

FSD has agreed to issue common share purchase warrants to purchase 625,000 shares of the Company. The warrants will expire 24 months after the vesting criteria has been met with an exercise price ranging from $1.50 CAD to $3.00 CAD.

About FSD Pharma

FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc., a wholly owned subsidiary, is focused on pharmaceutical research and development of its lead compound, FSD201, a proprietary ultra-micronized PEA formulation, for the treatment of inflammatory diseases. Lucid Psychss Inc., a wholly owned subsidiary, is focused on the research and development of its lead compounds, Lucid-Psych and Lucid-MS. Lucid-Psych is a molecular compound identified for the potential treatment of mental health disorders, and expanding this category, the Company is investigating other products addressing acute medical needs due to the abuse of drugs such as alcohol. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders.

Forward Looking Information

This press release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “plans”, “expects”, “expected”, “scheduled”, “estimates”, “intends”, “anticipates”, “hopes”, “planned” or “believes”, or variations of such words and phrases, or states that certain actions, events or results “may”, “could”, “would”, “might”, “potentially” or “will” be taken, occur or be achieved. More particularly, and without limitation, this press release contains forward-looking statements contained in this press release include statements concerning the future of FSD Pharma Inc. and are based on certain assumptions that FSD Pharma has made in respect thereof as of the date of this press release. FSD Pharma cannot give any assurance that such forward-looking statements will prove to have been correct.